The global drug discovery market was valued at USD XX billion in 2016 and is estimated to be valued at USD XX billion in 2017. The market is expected to reach USD XX billion by 2022, registering a healthy CAGR of XX%, during 2017-2022 (the forecast period). —
Drug discovery is a process of identifying a new medicines for clinical conditions. There is an ever increasing need for discovering new drug candidates due to the prevalence of several life-threatening diseases. Drug discovery technologies significantly contribute to the growth of pharmaceutical industries.
Request a Sample of Global Pet Utility Products Market Report@ http://www.orbisresearch.com/contacts/request-sample/321415 .
The major factors driving the growth of the drug discovery market include high prevalence of health disorders such as genetic disorders, nervous system disorders, diabetes, cardiovascular diseases and others; rising demand for novel drug discovery technologies owing to the growing population; and advancements in the field of biotechnology, molecular biology and genomics. In addition, populated pipeline for novel drugs coupled with patent expiry of several other drugs and increased expenditure on healthcare are also driving the market growth. However, huge investments, shift of market branded drugs to generic drugs and delayed processing of government regulations are hindering the market growth.
The drug discovery market is segmented on the basis of technology, services, end-users and geography. On the basis of technology, the market is segmented into QPCR, DNA microarrays, protein microarrays, high-throughput screening, mass spectrometry, gel electrophoresis, chromatography, protein & nucleic acid isolation and other technologies. Based on services, the market is segmented into Drug Metabolism and Pharmacokinetics (DMPK) services, pharmaceutical services, chemical services and biological services. The end-users of drug discovery market include research institutes, biotech companies, and pharmaceutical companies, among others.
Browse the Full Report @ http://www.orbisresearch.com/reports/index/global-drug-discovery-market-growth-trends-and-forecast-2017-2022 .
Based on geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The market is further segmented, geographically, by the countries in the respective regions.
Some of the major players in this market include:
Johnson And Johnson
Bayer AG Sanofi
Pfizer, Merck & Co. INC.
Boehringer Ingelheim, INC.
Roche Holding AG
Sanofi, formerly Sanofi-Aventis
Charles River Laboratories
Merck & Co. Inc.
Market analysis, with region-specific assessments and competition analysis on a global and regional scale
Market definition along with the identification of key drivers and restraints
Identification of factors instrumental in changing the market scenario, growing prospective opportunities, and identification of key companies that can influence the market
Extensively researched competitive landscape section with profiles of major companies, along with their market share
Identification and analysis of the macro and micro factors that affect the market on both, global and regional scales
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-range of knowledge and insights about the major players in the industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions where the industry is growing, and identify the regions that are still untapped."
Table of Content
2. Research Approach and Methodology
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increase in healthcare expenditure
6.1.2 Highly robust and populated pipeline for novel drugs
6.1.3 Upsurge in the therapeutic discovery ventures
6.2 Market Restraints
6.2.1 Stringent regulations for drug discovery
6.2.2 Market shift from branded to generic drugs
6.4 Key Challenges
7. Market Segmentation
7.1 By Technology
7.2 By Service
7.3 By End Users
8. Global Drug Discovery Market, by Geography
8.1 North America
8.2.6 Rest of Europe
8.3.5 South Korea
8.3.6 Rest of APAC
8.4 Middle East and Africa
8.4.2 South Africa
8.4.3 Rest of Middle East and Africa
8.5 South America
8.5.3 Rest of South America
10. Key players
10.2 Charles River Laboratories
10.3 Albany Molecular Research Inc.
10.4 Boehringer Ingelheim GmBh
10.6 BAYER AG
10.7 Jubilant Biosys
10.9 JOHNSON AND JOHNSON
10.10 ASTRAZENECA PLC
10.11 PFIZER, INC
10.12 GLAXOSMITHKLINE LLC
10.13 ELI LILY
10.14 MERCK & CO. INC
10.15 ROCHE HOLDING AG
11. Future Outlook of the Market
Make an enquire of this report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/321415 .
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Release ID: 211711